Drugs.com New Drug ApplicationsOriginal article
Novo Provides Update on the Denecimig Biologics License Application (BLA) in the US
BLA FilingdenecimigNeutral
AI Analysis
Summary
Novo Nordisk announced an FDA update regarding the Biologics License Application for denecimig in haemophilia A treatment. The article provides limited details on the status or outcome of the BLA review.
Importance:5/10
Sentiment:
0.00
denecimighaemophilia ABLAFDA
Related Companies
Read the original article
Published by Drugs.com New Drug Applications on October 2, 2026 9:10 PM